Christopher B. Prentiss
2020
In 2020, Christopher B. Prentiss earned a total compensation of $620.8K as Chief Financial Officer at Adamas Pharmaceuticals, a 43% decrease compared to previous year.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Non-Equity Incentive Plan | $184,000 |
| Salary | $386,667 |
| Stock Awards | $23,200 |
| Other | $6,912 |
| Total | $620,779 |
Prentiss received $386.7K in salary, accounting for 62% of the total pay in 2020.
Prentiss also received $20K in bonus, $184K in non-equity incentive plan, $23.2K in stock awards and $6.9K in other compensation.
Rankings
In 2020, Christopher B. Prentiss' compensation ranked 10,392nd out of 13,090 executives tracked by ExecPay. In other words, Prentiss earned more than 20.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,392 out of 13,090 | 21st |
Division Manufacturing | 4,452 out of 5,620 | 21st |
Major group Chemicals And Allied Products | 1,845 out of 2,253 | 18th |
Industry group Drugs | 1,616 out of 1,953 | 17th |
Industry Pharmaceutical Preparations | 1,194 out of 1,458 | 18th |
Source: SEC filing on April 19, 2021.
Prentiss' colleagues
We found two more compensation records of executives who worked with Christopher B. Prentiss at Adamas Pharmaceuticals in 2020.